94.4% of patients with sleep conditions report effective treatment: results from the UK’s largest medical cannabis survey
9 min read
Sam North
Sleep problems among UK medical cannabis patients are often experienced as symptoms linked to conditions such as anxiety, depression, and chronic pain, but can also present as primary diagnoses. In the largest UK patient survey of its kind, 94.4% of respondents reported meaningful treatment effectiveness when prescribed to help with sleep concerns, with 82% noticing changes within the first week and 97.9% reporting improved quality of life.
Sleep issues are among the most commonly reported challenges for UK residents prescribed medical cannabis, but for many of our patients, they rarely exist in isolation. They tend to arrive as part of a wider picture, intertwined with conditions such as anxiety, depression, or conditions that cause chronic pain, shaping not just how patients sleep, but how they move through the day.
Contents
In November 2025, we conducted the largest survey of active UK medical cannabis patients to date, gathering responses from 1,669 individuals. Within this dataset, 329 respondents reported sleep-related conditions. Of these 329 respondents, 28.6% (94) identified sleep as a primary diagnosis, while 71.4% (235) reported it as a secondary symptom.
Taken together, the data points to a clear and difficult-to-ignore positive impact of clinically guided medical cannabis treatment for sleep issues.
Summary of key findings on medical cannabis and sleep
|
Area |
Key finding |
What it shows in real-world patient care |
|
Treatment effectiveness |
94.4% (304/322) report moderate to extremely effective outcomes |
The vast majority of patients experience meaningful symptom relief when treatment is clinically guided and adjusted over time |
|
Role of sleep in diagnosis |
71.4% (235/329) report sleep as a secondary symptom |
Sleep disruptions are most often driven by underlying conditions such as anxiety, depression, or chronic pain rather than treated as a standalone issue |
|
Quality of life impact |
97.9% (322/329) report improved quality of life, with 70.5% (232/329) reporting significant improvement |
Improvements extend beyond sleep, affecting general quality of life, daily routine, and overall wellbeing |
|
Speed of perceived effects |
97.2% (308/317) report noticing changes within the first month, including 82.0% (260/317) within the first week and 56.1% (178/317) within 24 hours |
Many patients report relatively rapid changes in symptoms, which may contribute to earlier improvements in sleep patterns |
|
Side effects |
85.7% (282/329) report no side effects |
Most patients tolerate treatment well under specialist supervision, with side effects typically mild and manageable when they occur |
71.4% of patients report sleep issues as a secondary symptom rather than a primary condition
While UK medical cannabis can be legally prescribed for sleep conditions in its own right, the data showed that for most patients, it formed part of a wider clinical picture. Of the 329 respondents reporting sleep-related issues, 71.4% (235) experienced them as a secondary symptom, compared to 28.6% (94) who identified sleep as their primary diagnosis.
And for many of the respondents, improvements in sleep made a big difference to their overall health and wellbeing.
Which conditions were most commonly linked to sleep disruption?
Among patients who reported sleep as a secondary symptom, a consistent pattern emerged. Sleep disruption was most commonly associated with mental health and pain-related conditions, alongside a smaller number of neurological and mixed-condition presentations.
The most frequently reported conditions where sleep was a secondary symptom included:
-
Combined anxiety and depression
-
Osteoarthritis
94.4% of patients report meaningful effectiveness when taking UK medical cannabis for sleep conditions
Across the sleep cohort, including patients with insomnia, 304 of 322 respondents (94.4%) reported their treatment as at least moderately effective. Only 3 respondents (0.9%) reported no efficacy at all.
This pattern was seen across both primary sleep conditions and cases where sleep disruption was reported as a secondary symptom. Outcomes were generally positive, but not uniform.
|
Effectiveness rating |
% of patients |
Number of patients |
|
Extremely effective |
37.9% |
122 |
|
Very effective |
40.7% |
131 |
|
Moderately effective |
15.8% |
51 |
|
Slightly effective |
4.7% |
15 |
|
Not effective at all |
0.9% |
3 |
|
Total effective (≥ moderate) |
94.4% |
304/322 |
82.0% of patients notice effects within the first week of medical cannabis treatment
Most respondents reported relatively early changes after starting treatment. Of the 317 who answered this question, 82.0% (260) noticed effects within the first week, including 56.1% (178) who reported changes within the first day.
How quickly does medical cannabis affect sleep and symptoms?
For some patients, changes were noticed quickly, while for others, improvements developed more gradually over time. As with all prescribed treatments, individual response varied depending on the condition being treated, dosing, and ongoing clinical support.
|
Timeframe |
% of patients |
Number of patients |
|
Within the first day |
56.1% |
178 |
|
Within the first week |
82.0% |
260 |
|
Within first month |
97.2% |
308 |
Only 2.8% of respondents (9 out of 317) reported that it took longer than one month to notice changes, although a small number of patients elsewhere in the dataset reported no perceived effectiveness.
97.9% of patients reported improved quality of life, with 85.4% reporting better day-to-day functioning
With better sleep came wider improvements in daily functioning and overall quality of life. Of the 329 respondents, 322 (97.9%) described a positive shift in their overall quality of life, including 232 (70.5%) who considered that change significant.
A similar pattern carried through into everyday life. In total, 281 respondents (85.4%) said they were better able to manage daily tasks including work and other daily responsibilities, showing that positive secondary outcomes were felt across the board
How does improved sleep contribute to overall quality of life?
Patients commonly described:
-
A steadier mood and greater emotional balance
-
Less fatigue, with more reliable energy across the day
-
A more consistent rhythm to daily life
-
Increased independence in routine activities and work
|
Outcome |
% of patients |
Number of patients |
|
Significant improvement |
70.5% |
232 |
|
Slight improvement |
27.4% |
90 |
|
No change |
1.8% |
6 |
|
Worsened |
0.3% |
1 |
|
Total improved |
97.9% |
322 |
85.7% of patients report no side effects from UK medical cannabis treatment
As with all prescribed medical treatments, side effects form part of the wider picture of how a treatment performs in real-world settings. Medical cannabis can cause side effects, but in most cases these were mild, and were managed through discussion with clinicians who make up Releaf’s world-class clinical team, and careful adjustments to treatment over time.
For patients being treated for sleep issues, most reported no adverse effects. Of the 329 respondents, 282 (85.7%) said they did not experience any side effects whatsoever from their Releaf prescribed medical cannabis
How does medical cannabis compare to lifestyle changes and natural alternatives for sleep support?
While medical cannabis is a ‘natural’ treatment option, it sits in a very different category to many of the other natural alternatives for sleep. As a prescribed treatment, it is assessed, monitored, and adjusted over time with full clinical oversight from a specialist doctor, rather than being self-directed.
That difference is key to point out. Combined with growing patient-reported data and clinical research, it reflects a more structured, individualised approach to managing sleep-related symptoms.
Does that mean that medical cannabis for sleep issues is more effective than supplements like melatonin and magnesium?
Not necessarily. They tend to be used in different situations. Supplements like melatonin or magnesium are often tried first for general sleep support, while medical cannabis is usually considered when sleep issues are linked to a diagnosed condition or haven’t responded to standard approaches.
What about lifestyle changes for sleep issues?
Lifestyle changes are a crucial piece of the puzzle when it comes to improving sleep. Think of this as the foundation, the daily habits that shape how the body winds down, how consistent sleep becomes, and how well rest is maintained over time.
This might include:
- establishing a regular sleep schedule (7 to 8 hours a night is ideal for most adults)
- reducing screen exposure in the evening (especially blue light)
- managing caffeine intake (no caffeine after 2 pm is often recommended)
- creating an environment that supports rest (temperature and light control)
How can UK patients access legal medical cannabis for sleep issues?
As the most trusted medical cannabis clinic in the UK, our care ethos is guided by specialist clinicians and supported through our Patient Dashboard, designed to manage prescriptions, follow-ups, and ongoing treatment with regular follow-up consultations to ensure that your medical cannabis treatment continues to be as effective as possible.
To see if treatment could be suitable for you, try our medical cannabis eligibility checker. It’s free, takes less than 20 seconds, and could be the first step towards finding better health outcomes.
Releaf - Let's rethink healthcare
Did you like this article?
It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.
Blog Categories
Further reading
94.4% of patients with sleep conditions report effective treatment: results from the UK’s largest medical cannabis survey
Based on UK patient data from 329 respondents within a wider survey of 1,669 participants, 94.4% say medical cannabis is effective for sleep-related conditions, with 82% noticing changes within the first week and 97.9% experiencing improved quality of life. The findings come from the largest ever survey of active UK medical cannabis patients.
UK cannabis attitudes in 2026: YouGov data and what real patients experience
The UK remains divided on cannabis in 2026, according to new YouGov data. When compared with insights from the UK’s largest medical cannabis patient survey, a different picture begins to emerge, highlighting the gap between public perception and real patient experience.
Decoding Cannabis: does cannabis cause cognitive decline? What a 44-year study found
A major Danish study followed more than 5,000 men for over four decades to understand how cannabis use affects cognitive decline. The findings challenge common assumptions, showing no evidence of accelerated decline. But what does this actually mean for your brain health over time?